Manufacturers Life Insurance Company, The Adaptive Biotechnologies Corp Transaction History
Manufacturers Life Insurance Company, The
- $108 Billion
- Q3 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 47,283 shares of ADPT stock, worth $270,931. This represents 0.0% of its overall portfolio holdings.
Number of Shares
47,283
Previous 48,834
3.18%
Holding current value
$270,931
Previous $176,000
37.5%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding ADPT
# of Institutions
202Shares Held
146MCall Options Held
68.8KPut Options Held
42.5K-
Viking Global Investors LP30MShares$172 Million0.59% of portfolio
-
Rubric Capital Management LP New York, NY14.4MShares$82.5 Million2.05% of portfolio
-
Black Rock Inc. New York, NY11.7MShares$66.8 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl11.6MShares$66.5 Million0.56% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.6MShares$61 Million0.0% of portfolio
About Adaptive Biotechnologies Corp
- Ticker ADPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 142,872,992
- Market Cap $819M
- Description
- Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...